Prognostic and predictive value of pathohistological features in gastric cancer and identification of SLITRK4 as a potential biomarker for gastric cancer

被引:1
|
作者
Zhang, Yuzhe [1 ]
Xue, Yuhang [2 ]
Gao, Yongju [2 ]
Zhang, Ye [1 ]
机构
[1] China Med Univ, Hosp 1, Lab Canc Res Inst 1, 155 Nanjing North St, Shenyang 110001, Peoples R China
[2] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Nucl Med, Henan Key Lab Mol Nucl Med & Translat Med,Peoples, Zhengzhou 450003, Peoples R China
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
中国国家自然科学基金;
关键词
Gastric cancer; Pathological image; SLITRK4; Machine learning; Classification and prognosis prediction; TUMOR-METASTASIS; IMMUNOTHERAPY; SIGNATURE; INSIGHTS; SUBTYPES; MODEL;
D O I
10.1038/s41598-024-80292-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of this study was to develop a quantitative feature-based model from histopathologic images to assess the prognosis of patients with gastric cancer. Whole slide image (WSI) images of H&E-stained histologic specimens of gastric cancer patients from The Cancer Genome Atlas were included and randomly assigned to training and test groups in a 7:3 ratio. A systematic preprocessing approach was employed as well as a non-overlapping segmentation method that combined patch-level prediction with a multi-instance learning approach to integrate features across the slide images. Subjects were categorized into high- or low-risk groups based on the median risk score derived from the model, and the significance of this stratification was assessed using a log-rank test. In addition, combining transcriptomic data from patients and data from other large cohort studies, we further searched for genes associated with pathological features and their prognostic value. A total of 165 gastric cancer patients were included for model training, and a total of 26 features were integrated through multi-instance learning, with each process generating 11 probabilistic features and 2 predictive labeling features. We applied a 10-fold Lasso-Cox regression model to achieve dimensionality reduction of these features. The predictive accuracy of the model was verified using Kaplan-Meyer (KM) curves for stratification with a consistency index of 0.741 for the training set and 0.585 for the test set. Deep learning-based resultant supervised pathohistological features have the potential for superior prognostic stratification of gastric cancer patients, transforming image pixels into an effective and labor-saving tool to optimize the clinical management of gastric cancer patients. Also, SLITRK4 was identified as a prognostic marker for gastric cancer.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Prohibitin as a potential biomarker for gastric cancer
    不详
    BIOMARKERS IN MEDICINE, 2008, 2 (05) : 443 - 443
  • [22] PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer
    Liu, Baohong
    Xiao, Xingxing
    Lin, Ziqin
    Lou, Yongliang
    Zhao, Lingling
    CANCER BIOMARKERS, 2022, 34 (02) : 251 - 264
  • [23] Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological features
    Dittmar, Yves
    Settmacher, Utz
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (11) : 292 - 302
  • [24] AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer
    Nakamura, Shunsuke
    Kanda, Mitsuro
    Shimizu, Dai
    Tanaka, Chie
    Inokawa, Yoshikuni
    Hattori, Norifumi
    Hayashi, Masamichi
    Yamada, Suguru
    Nakayama, Goro
    Omae, Kenji
    Koike, Masahiko
    Kodera, Yasuhiro
    ANTICANCER RESEARCH, 2020, 40 (12) : 6713 - 6721
  • [25] Trastuzumab Specific Epitope Evaluation as a Predictive and Prognostic Biomarker in Gastric Cancer Patients
    Koh, Jiwon
    Nam, Soo Kyung
    Lee, Youn Woo
    Kim, Jin Won
    Lee, Keun-Wook
    Ock, Chan-Young
    Oh, Do-Youn
    Ahn, Sang-Hoon
    Kim, Hyung-Ho
    Kang, Keon-Wook
    Kim, Woo Ho
    Lee, Ho-Young
    Lee, Hye Seung
    BIOMOLECULES, 2019, 9 (12)
  • [26] Individualized treatment of gastric cancer:Impact of molecular biology and pathohistological features
    Yves Dittmar
    Utz Settmacher
    World Journal of Gastrointestinal Oncology, 2015, (11) : 292 - 302
  • [27] HER2 EXPRESSION IN CHINESE GASTRIC CANCER: ASSOCIATION WITH CLINICAL FEATURES, PREDICTIVE AND PROGNOSTIC VALUE
    Wang, Yan
    Xu, Jian-ming
    Lin, Li
    Ge, Fei-jiao
    Li, Shan-shan
    ANNALS OF ONCOLOGY, 2011, 22 : v42 - v42
  • [28] Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
    Hirofumi Tazawa
    Takahisa Suzuki
    Akihisa Saito
    Akira Ishikawa
    Toshiaki Komo
    Haruki Sada
    Norimitsu Shimada
    Naoto Hadano
    Takashi Onoe
    Takeshi Sudo
    Yosuke Shimizu
    Kazuya Kuraoka
    Hirotaka Tashiro
    Journal of Gastrointestinal Surgery, 2022, 26 : 305 - 313
  • [29] Utility of TMPRSS4 as a Prognostic Biomarker and Potential Therapeutic Target in Patients with Gastric Cancer
    Tazawa, Hirofumi
    Suzuki, Takahisa
    Saito, Akihisa
    Ishikawa, Akira
    Komo, Toshiaki
    Sada, Haruki
    Shimada, Norimitsu
    Hadano, Naoto
    Onoe, Takashi
    Sudo, Takeshi
    Shimizu, Yosuke
    Kuraoka, Kazuya
    Tashiro, Hirotaka
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (02) : 305 - 313
  • [30] Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer
    Yang, Shifeng
    Zou, Xiaoming
    Yang, Hao
    Li, Jiacheng
    Zhang, Ange
    Zhang, Lisha
    Li, Changjian
    Zhu, Lei
    Ma, Zhen
    FRONTIERS IN GENETICS, 2022, 13